Mark C. Wiggins

Mark C. Wiggins is a declared insider at 3 companies (board member); the most frequent names are Biogen Inc., Tracon Pharmaceuticals, Inc. and Zogenix, Inc. Over a trading history stretching from 30 July 2004 to 7 March 2022, the count stands at 158 filings.

Market trades split into 5 purchases (€99k) and 112 sales (€20.7M). On balance, insiders were net sellers of €20.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 12 share grants and 28 option exercises.

The median purchase comes to €18k. On 4 out of 5 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 9 March 2022 with a transaction in Zogenix, Inc. The clock since the last published purchase (30 December 2020) now reads 2,123 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.